This paper is only available as a PDF. To read, Please Download here.
Since the introduction of PGT, the indications for PGD are gradually expanding. Initially
performed mainly for childhood-onset genetic conditions with clearly defined penetrance,
severity and disease phenotypes, PGT is now applied to common late onset conditions
determined by genetic predisposition, which may be realized with age or not realized
in a lifetime. We present here the experience of PGT for these borderline indications
in our series of over 17,000 PGT cases, which includes 5,780 PGT-M
Of the521 conditions tested, the borderline indications included71 cycles for cardiac
conditions, 461 cycles for HLA matching and 702 cycles for cancer predisposition.
Combined, these 1,163 cycles represent 20.1% of the overall cases. The most common
cardiac genetic condition was Dilated Cardiomyopathy (DCM), 5causatives genes (over
30 different mutations), as well as Hypertrophic Cardiomyopathy (HCM) with 6 causative
genes (over 16 different mutations). These cycles resulted in birth of 32 cardiac
disease predisposition free children. The largest group for non-traditional indications
was PGT-M for 23 cancer predisposition syndromes (642 cases overall), including BRCA1
and BRCA2, accounting for more than a third of the cases (32.7%; 210/642). These cycles
resulted in birth of 271children free of cancer predisposition genes, which is the
world's largest series. The number of cases for cancer predisposition syndromes has
increased steadily since 1999, after we performed the world's fist PGT. The other
group of PGT for non-traditional indications is PGT for HLA matching, which was requested
either in combination with PGT-M (73.5% (339/461), or exclusively for HLA typing (26.5%
(122/461), with or without PGT-A. Referrals for PGT are becoming increasingly complex
as the improving testing technologies identify a wide genetic heterogeneity, variable
severity and penetrance of adult onset conditions, for which the application of PGT
may present importance ethical problems. However, our experience shows the increasing
referral for PGT of such conditions, which was extremely accurate and efficient, allowing
couples at risk to produce the offspring free of genes predisposing to common conditions
of later life.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Reproductive BioMedicine OnlineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2019 Published by Elsevier Inc.